|
AU2587297A
(en)
*
|
1996-03-25 |
1997-10-17 |
Eli Lilly And Company |
Method for treating pain
|
|
ZA977967B
(en)
*
|
1996-09-23 |
1999-03-04 |
Lilly Co Eli |
Combination therapy for treatment of psychoses
|
|
ES2151828B1
(es)
|
1998-07-10 |
2001-08-16 |
Esteve Labor Dr |
Empleo de derivados de tetrahidropiridinas (ohidroxi-piperidinas)-b utilazoles en la elaboracion de un medicamento para el tratamiento del dolor.
|
|
ES2194536T3
(es)
|
1998-11-13 |
2003-11-16 |
Lilly Co Eli |
Combinacion de duloxetina con farmacos antiinflamatorios no esteroideos.
|
|
US6280763B1
(en)
|
1999-05-10 |
2001-08-28 |
Pierce Management, Llc |
Apparatus and method for transdermal delivery of bupropion
|
|
DE19924929C2
(de)
*
|
1999-05-31 |
2001-05-31 |
Elegene Gmbh |
Neues Verfahren zur Untersuchung der Eignung eines Materials als Pharmakon
|
|
SK286667B6
(sk)
|
1999-07-01 |
2009-03-05 |
Pharmacia & Upjohn Company |
Použitie opticky čistého (S,S)-reboxetínu alebo jeho farmaceuticky prijateľnej soli na výrobu lieku na liečenie alebo prevenciu chronického únavového syndrómu
|
|
US20040115133A1
(en)
*
|
2000-05-10 |
2004-06-17 |
Wermeling Daniel P. |
Intranasal opioid compositions
|
|
US20060083691A1
(en)
*
|
2000-05-10 |
2006-04-20 |
Wermeling Daniel P |
Intranasal opioid compositions, delivery devices and methods of using same
|
|
WO2002060870A2
(en)
*
|
2000-11-17 |
2002-08-08 |
Adolor Corporation |
Delta agonist analgesics
|
|
DE10112798A1
(de)
*
|
2001-03-16 |
2002-10-02 |
Elegene Gmbh |
Vorrichtung und Verfahren zur automatischen Erzeugung einer Wärmevermeidungsreaktion von Nematoden oder ähnlichen Lebewesen
|
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
|
DE10141650C1
(de)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
|
SE0102855D0
(sv)
*
|
2001-08-27 |
2001-08-27 |
Astrazeneca Ab |
Method of treatment
|
|
US7288246B2
(en)
|
2001-09-13 |
2007-10-30 |
The Board Of Regents Of The University Of Oklahoma |
Method of alleviating chronic pain via peripheral glutaminase regulation
|
|
US6635675B2
(en)
*
|
2001-11-05 |
2003-10-21 |
Cypress Bioscience, Inc. |
Method of treating chronic fatigue syndrome
|
|
US6602911B2
(en)
|
2001-11-05 |
2003-08-05 |
Cypress Bioscience, Inc. |
Methods of treating fibromyalgia
|
|
JP2006505489A
(ja)
*
|
2002-02-08 |
2006-02-16 |
アボット・ラボラトリーズ |
精神分裂病の治療のための併用療法
|
|
AU2003213009A1
(en)
*
|
2002-02-12 |
2003-09-04 |
Cypress Bioscience, Inc. |
Methods of treating attention deficit/hyperactivity disorder (adhd)
|
|
EP2085072A1
(en)
*
|
2002-03-26 |
2009-08-05 |
Teva Pharmaceutical Industries Ltd. |
Drug microparticles
|
|
EP1499309A4
(en)
*
|
2002-04-24 |
2008-05-28 |
Cypress Bioscience Inc |
PREVENTION AND TREATMENT OF FUNCTIONAL SOMATIC DISEASES, INCLUDING STRESS-BASED DISEASES
|
|
WO2003101492A2
(en)
*
|
2002-05-30 |
2003-12-11 |
Neurosearch A/S |
Combination of atypical antipsychotic and serotonin reuptake inhibitor for the treatment of chronic pain
|
|
US20040220153A1
(en)
*
|
2002-09-24 |
2004-11-04 |
Jost-Price Edward Roydon |
Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
|
|
EP1558231A4
(en)
*
|
2002-10-03 |
2010-09-08 |
Cypress Bioscience Inc |
DOSAGE CLIMBING AND FRICTIONAL DAILY DOSE OF ANTIDEPRESSANTS TO TREAT NEUROLOGICAL DISORDERS
|
|
EP1565184A1
(en)
*
|
2002-11-26 |
2005-08-24 |
Alexza Molecular Delivery Corporation |
Treatment of headache with antipsychotics delivered by inhalation
|
|
EP1567164B1
(en)
|
2002-11-26 |
2009-01-14 |
Alexza Pharmaceuticals, Inc. |
Use of loxapine for the manufacture of a medicament for the treatment of pain
|
|
AR042806A1
(es)
|
2002-12-27 |
2005-07-06 |
Otsuka Pharma Co Ltd |
Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
|
|
KR100858852B1
(ko)
|
2002-12-27 |
2008-09-17 |
오쓰까 세이야꾸 가부시키가이샤 |
기분 장애 치료용 카르보스티릴 유도체 및 세로토닌 재흡수억제제
|
|
WO2004104493A2
(en)
|
2003-05-21 |
2004-12-02 |
Alexza Pharmaceuticals, Inc. |
Methods of controlling uniformity of substrate temperature and self-contained heating unit and drug-supply unit employing same
|
|
EP2601953A1
(en)
*
|
2003-05-23 |
2013-06-12 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril derivatives and mood stabilizers for treating mood disorders
|
|
WO2004105690A2
(en)
*
|
2003-05-23 |
2004-12-09 |
Cypress Bioscience, Inc. |
Treatment of chronic pain associated with drug or radiation therapy
|
|
NZ527142A
(en)
*
|
2003-07-23 |
2006-03-31 |
Douglas Pharmaceuticals Ltd |
A stable suspension formulation
|
|
US7795266B2
(en)
*
|
2003-09-25 |
2010-09-14 |
Helton David R |
Tetrahydroindolone derivatives for treament of neurological conditions
|
|
US20050107439A1
(en)
*
|
2003-11-10 |
2005-05-19 |
Helton David R. |
Composition and method for treating emesis
|
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
|
MY147767A
(en)
|
2004-06-16 |
2013-01-31 |
Janssen Pharmaceutica Nv |
Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
|
|
CA2576961A1
(en)
|
2004-08-12 |
2006-03-02 |
Alexza Pharmaceuticals, Inc. |
Aerosol drug delivery device incorporating percussively activated heat packages
|
|
JP2008545650A
(ja)
|
2005-05-20 |
2008-12-18 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
スルファミド誘導体の製造方法
|
|
UA97349C2
(uk)
*
|
2005-09-08 |
2012-02-10 |
Х. Луннбэк А/С |
Стійкі тверді склади сертиндолу
|
|
US7994220B2
(en)
*
|
2005-09-28 |
2011-08-09 |
Cypress Bioscience, Inc. |
Milnacipran for the long-term treatment of fibromyalgia syndrome
|
|
EP1795609A1
(en)
|
2005-12-06 |
2007-06-13 |
Sanofi-Aventis Deutschland GmbH |
Method for the diagnosis and treatment of cardiovascular diseases
|
|
WO2007067714A2
(en)
*
|
2005-12-08 |
2007-06-14 |
The Mclean Hospital Corporation |
Treatment of sequelae of psychiatric disorders
|
|
US8716231B2
(en)
|
2005-12-19 |
2014-05-06 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
|
|
US8691867B2
(en)
|
2005-12-19 |
2014-04-08 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
|
|
US8497298B2
(en)
|
2005-12-19 |
2013-07-30 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
|
|
US8937096B2
(en)
|
2005-12-19 |
2015-01-20 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
|
|
US8492431B2
(en)
|
2005-12-19 |
2013-07-23 |
Janssen Pharmaceutica, N.V. |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
|
|
WO2007137167A2
(en)
|
2006-05-19 |
2007-11-29 |
Janssen Pharmaceutica N.V. |
Co-therapy for the treatment of epilepsy
|
|
EP2121088B1
(en)
|
2007-03-09 |
2016-07-13 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
|
WO2008128166A1
(en)
*
|
2007-04-13 |
2008-10-23 |
Concert Pharmaceuticals Inc. |
Deuterated derivatives of 4-(6-fluoro-1, 2-benzisoxazol-3-yl) piperidine compounds
|
|
EP2219648A4
(en)
*
|
2007-11-09 |
2010-11-03 |
Cenomed Biosciences Llc |
TREATMENT OF POSTRAUMATIC STRESS WITH TETRAHYDROINDOLONE ARYLPIPERAZINE COMPOUNDS
|
|
US20090264443A1
(en)
*
|
2008-04-18 |
2009-10-22 |
David Helton |
Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
|
|
PE20110060A1
(es)
|
2008-06-23 |
2011-01-31 |
Janssen Pharmaceutica Nv |
Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo[1,4]dioxin-2-ilmetil)-sulfamida
|
|
US8815939B2
(en)
|
2008-07-22 |
2014-08-26 |
Janssen Pharmaceutica Nv |
Substituted sulfamide derivatives
|
|
US8697735B2
(en)
|
2008-07-25 |
2014-04-15 |
Bionevia Pharmaceuticals, Inc. |
Solid forms of epalrestat
|
|
PL2326632T3
(pl)
|
2008-09-06 |
2017-10-31 |
Bionevia Pharmaceuticals Inc |
Nowy kokryształ choliny i epalrestatu
|
|
BR112014032777A2
(pt)
*
|
2012-07-02 |
2017-06-27 |
Pnb Vesper Life Science Pvt Ltd |
ligantes de receptor de colecistocinina inovadores
|
|
US20140206667A1
(en)
|
2012-11-14 |
2014-07-24 |
Michela Gallagher |
Methods and compositions for treating schizophrenia
|
|
MX2021011641A
(es)
|
2013-12-24 |
2023-03-10 |
Durect Corp |
Usos de sulfatos de colesterol oxigenados (soc).
|
|
EP3468540A4
(en)
*
|
2016-06-13 |
2020-03-18 |
Board Of Regents Of the University Of Texas System |
PHARMACEUTICAL COMPOSITIONS AND METHOD FOR TREATING PAIN
|
|
US12459965B2
(en)
|
2017-10-09 |
2025-11-04 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
GB2571696B
(en)
|
2017-10-09 |
2020-05-27 |
Compass Pathways Ltd |
Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
|
|
WO2019152873A1
(en)
|
2018-02-02 |
2019-08-08 |
Alexza Pharmaceuticals, Inc. |
Electrical condensation aerosol device
|
|
US12433904B2
(en)
|
2019-04-17 |
2025-10-07 |
Compass Pathfinder Limited |
Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
|
|
US12389955B2
(en)
*
|
2021-10-22 |
2025-08-19 |
Nike, Inc. |
Garment adjusting system
|
|
US11977085B1
(en)
|
2023-09-05 |
2024-05-07 |
Elan Ehrlich |
Date rape drug detection device and method of using same
|